Susquehanna International Group’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-45,105
| Closed | -$134K | – | 13778 |
|
|
2023
Q3 | $134K | Buy |
+45,105
| New | +$105K | ﹤0.01% | 10661 |
|
|
2022
Q4 | – | Sell |
-6,409
| Closed | -$38K | – | 14550 |
|
|
2022
Q3 | $38K | Buy |
+6,409
| New | +$53.8K | ﹤0.01% | 12362 |
|
|
2022
Q2 | – | Sell |
-987
| Closed | -$19K | – | 14444 |
|
|
2022
Q1 | $19K | Buy |
+987
| New | +$16.4K | ﹤0.01% | 12644 |
|
|
2021
Q4 | – | Sell |
-1,345
| Closed | -$61K | – | 14292 |
|
|
2021
Q3 | $61K | Buy |
+1,345
| New | +$65.9K | ﹤0.01% | 12282 |
|
|
2020
Q4 | – | Sell |
-295
| Closed | -$15K | – | 11951 |
|
|
2020
Q3 | $15K | Buy |
+295
| New | +$23.8K | ﹤0.01% | 10398 |
|
|
2019
Q4 | – | Sell |
-23
| Closed | -$5K | – | 10959 |
|
|
2019
Q3 | $5K | Sell |
23
-16
| -41% | -$3.83K | ﹤0.01% | 10050 |
|
|
2019
Q2 | $14K | Buy |
39
+38
| +3,800% | +$29.6K | ﹤0.01% | 10047 |
|
|
2019
Q1 | $1K | Sell |
1
-2
| -67% | -$3.24K | ﹤0.01% | 8693 |
|
|
2018
Q4 | $4K | Sell |
3
-6
| -67% | -$14.2K | ﹤0.01% | 8796 |
|
|
2018
Q3 | $25K | Sell |
9
-1
| -10% | -$2.89K | ﹤0.01% | 8972 |
|
|
2018
Q2 | $34K | Sell |
10
-2
| -17% | -$6.75K | ﹤0.01% | 9351 |
|
|
2018
Q1 | $42K | Buy |
+12
| New | +$35.6K | ﹤0.01% | 9010 |
|
|
2017
Q4 | – | Sell |
-2
| Closed | -$9K | – | 10116 |
|
|
2017
Q3 | $9K | Buy |
+2
| New | +$10.3K | ﹤0.01% | 8690 |
|
|
2016
Q1 | – | Sell |
-2
| Closed | -$48K | – | 9876 |
|
|
2015
Q4 | $48K | Buy |
+2
| New | +$37.8K | ﹤0.01% | 9110 |
|
Susquehanna International Group's TMBR Position: Q4 2023 in Review
Susquehanna International Group sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q4 2023, closing a stake of 45,105 shares — an estimated $134K sold.
Susquehanna International Group first reported a position in TMBR in Q4 2015 and held it in 14 quarters. The position peaked at $134K in Q3 2023. 0 funds tracked by Wall St. Rank hold TMBR as of Q4 2023.
- Susquehanna International Group reported no remaining Timber Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Susquehanna International Group sold 45,105 Timber Pharmaceuticals, Inc. shares in Q4 2023, an estimated $134K.
- Susquehanna International Group first reported a position in Timber Pharmaceuticals, Inc. in Q4 2015 and held it in 14 quarters.
- Susquehanna International Group's Timber Pharmaceuticals, Inc. position peaked at $134K in Q3 2023.
- 0 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q4 2023.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.